Maryland Researchers Enrolling Type 2 Patients in Long-Term Drug Study
BALTIMORE-Researchers at the University of Maryland School of Medicine are enrolling patients with type 2 diabetes into an NIH-funded clinical
Read more
Dpp-4 Inhibitor
Lilly Begins Sales of Jentadueto, a Combo Drug for Type 2s
Eli Lilly and Company has begun US sales of Jentadueto, a drug for type 2 diabetes that combines Tradjenta and
Read more
FDA OKs Sale of Combo Drug JANUMET
The FDA has approved US sales of JANUMET® XR, a daily oral treatment for type 2 diabetes that combines sitagliptin
Read more
A Conversation About Janumet and Earlier Combination Therapy for Type 2 Diabetes
Combination therapy, in which doctors prescribe more than one drug to treat type 2 diabetes, is a fairly common practice.
Read more